首页 › 基金 › Redmile Group, LLC › CLYM

Redmile Group, LLC 对 CLYM 的持仓历史

CLIMB BIO INC · 医疗保健

Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 CLYM(CLIMB BIO INC)1,226,330 股,市值约 US$16.0M,约占其申报组合的 1.07%,在其申报持仓中市值排名第 20 位。 Redmile Group, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.23M 股
申报持仓市值$15.99M
组合权重1.07%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Redmile Group, LLC 对 CLYM 的持仓演变

Redmile Group, LLC 于 Q2 2026 首次披露 CLYM 持仓:1,226,330 股(约 US$16.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.23M $15.99M 新进

关于 CLYM 与 13F 数据

CLYM(CLIMB BIO INC)属于医疗保健行业。我们追踪的基金中还有 75 只申报持有 CLYM,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CLYM 的基金

查看 CLYM 的全部基金持有人 →

常见问题

How long has Redmile Group, LLC held CLYM?

Redmile Group, LLC has disclosed CLYM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Redmile Group, LLC's current position in CLYM?

As of Q2 2026, Redmile Group, LLC holds 1.23M shares of CLYM (CLIMB BIO INC), valued at $15.99M, representing 1.07% of its reported portfolio and ranking #20.

Has Redmile Group, LLC been buying or selling CLYM?

In the latest 13F filing (Q2 2026), Redmile Group, LLC newly opened its position in CLYM.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.